- Location
-
Deutsche Nationalbibliothek Frankfurt am Main
- ISSN
-
1465-542X
- Extent
-
Online-Ressource
- Language
-
Englisch
- Notes
-
online resource.
- Bibliographic citation
-
Epigenetic silencing of DSC3 is a common event in human breast cancer ; volume:7 ; number:5 ; day:16 ; month:6 ; year:2005 ; pages:1-12 ; date:10.2005
Breast cancer research ; 7, Heft 5 (16.6.2005), 1-12, 10.2005
- Creator
-
Oshiro, Marc M.
- Contributor
-
Kim, Christina J.
Wozniak, Ryan J.
Junk, Damian J.
Muñoz-Rodríguez, José L.
Burr, Jeanne A.
Fitzgerald, Matthew
Pawar, Sangita C.
Cress, Anne E.
Domann, Frederick E.
Futscher, Bernard W.
SpringerLink (Online service)
- DOI
-
10.1186/bcr1273
- URN
-
urn:nbn:de:1111-2016032356867
- Rights
-
Der Zugriff auf das Objekt ist unbeschränkt möglich.
- Last update
-
14.08.2025, 10:50 AM CEST
Data provider
This object is provided by:
Deutsche Nationalbibliothek. If you have any questions about the object, please contact the data provider.
Deutsche Nationalbibliothek. If you have any questions about the object, please contact the data provider.
Associated
- Oshiro, Marc M.
- Kim, Christina J.
- Wozniak, Ryan J.
- Junk, Damian J.
- Muñoz-Rodríguez, José L.
- Burr, Jeanne A.
- Fitzgerald, Matthew
- Pawar, Sangita C.
- Cress, Anne E.
- Domann, Frederick E.
- Futscher, Bernard W.
- SpringerLink (Online service)
Other Objects (12)
Epigenetic silencing of SALL2 confers tamoxifen resistance in breast cancer
Epigenetic silencing and deletion of the BRCA1gene in sporadic breast cancer
Epigenetic silencing of SALL 2 confers tamoxifen resistance in breast cancer
Epigenetic silencing of TGFBI confers resistance to trastuzumab in human breast cancer
Genetic and epigenetic silencing of the beclin 1gene in sporadic breast tumors
Expression profiling of DNA methylation-mediated epigenetic gene-silencing factors in breast cancer
Epigenetic silencing of serine protease HTRA1 drives polyploidy
Epigenetic silencing of MEIS2 in prostate cancer recurrence
Aberrant epigenetic and transcriptional events associated with breast cancer risk
Pharmacologic reversion of epigenetic silencing of the PRKD1promoter blocks breast tumor cell invasion and metastasis
YAP represses intestinal inflammation through epigenetic silencing of JMJD3
Epigenetic silencing of miR-375 induces trastuzumab resistance in HER2-positive breast cancer by targeting IGF1R
Epigenetic silencing of SALL2 confers tamoxifen resistance in breast cancer
Epigenetic silencing and deletion of the BRCA1gene in sporadic breast cancer
Epigenetic silencing of SALL 2 confers tamoxifen resistance in breast cancer
Epigenetic silencing of TGFBI confers resistance to trastuzumab in human breast cancer
Genetic and epigenetic silencing of the beclin 1gene in sporadic breast tumors
Expression profiling of DNA methylation-mediated epigenetic gene-silencing factors in breast cancer
Epigenetic silencing of serine protease HTRA1 drives polyploidy
Epigenetic silencing of MEIS2 in prostate cancer recurrence
Aberrant epigenetic and transcriptional events associated with breast cancer risk
Pharmacologic reversion of epigenetic silencing of the PRKD1promoter blocks breast tumor cell invasion and metastasis
YAP represses intestinal inflammation through epigenetic silencing of JMJD3
Epigenetic silencing of miR-375 induces trastuzumab resistance in HER2-positive breast cancer by targeting IGF1R
Epigenetic silencing of SALL2 confers tamoxifen resistance in breast cancer
Epigenetic silencing and deletion of the BRCA1gene in sporadic breast cancer
Epigenetic silencing of SALL 2 confers tamoxifen resistance in breast cancer
Epigenetic silencing of TGFBI confers resistance to trastuzumab in human breast cancer
Genetic and epigenetic silencing of the beclin 1gene in sporadic breast tumors
Expression profiling of DNA methylation-mediated epigenetic gene-silencing factors in breast cancer
Epigenetic silencing of serine protease HTRA1 drives polyploidy
Epigenetic silencing of MEIS2 in prostate cancer recurrence
Aberrant epigenetic and transcriptional events associated with breast cancer risk
Pharmacologic reversion of epigenetic silencing of the PRKD1promoter blocks breast tumor cell invasion and metastasis
YAP represses intestinal inflammation through epigenetic silencing of JMJD3